US Hospital Clinical Chemistry and Immunodiagnostics Market for 100 Tests: Supplier Shares and Sales Forecasts, 2019-2023

This new report contains 543 pages, 63 tables, and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: 

  • Major issues pertaining to the US clinical chemistry and immunodiagnostic hospital laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Five-year volume and sales forecasts for over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in US hospitals, including controls, calibrators and consumables.  
  • Five-year volume forecasts for serum, whole blood, plasma, CFS, urine and other specimens.
  • Five-year reagent and instrument sales forecasts. 
  • Review of current instrumentation technologies, and a feature comparison
    of high-, medium-, and low-volume/POC analyzers. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of current and emerging technologies and their potential market applications. 
  • Product development opportunities for clinical chemistry and immunodiagnostic instruments and consumables. 
  • Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Market penetration strategies, entry barriers and risks.


    Introduction
    Worldwide Market and Technology Overview

    A. Major Routine Chemistry Tests
    1. Albumin
    2. Alkaline Phosphatase
    3. ALT/SGPT
    4. Ammonia
    5. Amylase
    6. AST/SGOT
    7. Bilirubin, Total
    8. Blood Gases
    9. Blood Urea Nitrogen (BUN)
    10. Calcium
    11. Cardio CRP
    12. Cholesterol
    13. Cholinesterase
    14. CRP
    15. Creatinine
    16. Electrolytes
    a. Carbon Dioxide/Bicarbonate
    b. Chloride
    c. Potassium
    d. Sodium
    17. Ferritin
    18. Fructosamine
    19. Gamma-Glutamyl Transpeptidase (GGT)
    20. Glucose
    21. High Density Lipoprotein (HDL)
    22. Homocysteine
    23. Iron
    24. Lactate Dehydrogenase (LDH)
    25. Magnesium
    26. Phosphorus
    27. Protein
    28. Triglycerides
    29. Uric Acid
    30. Troponin

    B. Therapeutic Drug Monitoring (TDM)
    1. Overview
    2. Carbamazepine
    3. Cyclosporin
    4. Digoxin
    5. Everolimus
    6. Gentamicin
    7. Lamotrigine/Lamictal
    8. Levetiracetam
    9. Lidocaine
    10. Lithium
    11. NAPA/Procainamide
    12. Phenytoin
    13. Quinidine
    14. Sirolimus
    15. Tacrolimus
    16. Theophylline
    17. Topirimate
    18. Valproic Acid
    C. Endocrine Function Tests
    1. Cortisol
    2. Estradiol
    3. Follicle-Stimulating Hormone (FSH)
    4. Gastrin
    5. Growth Hormone/IGF-1
    6. Human Chorionic Gonadotropin (HCG)
    7. LH
    8. Progesterone
    9. PTH/IO PTH
    10. Prolactin
    11. T3
    12. T3 Free
    13. T3 Uptake
    14. T4 (Thyroxine)
    15. T4 Free
    16. TBG
    17. Testosterone
    18. Thyroglobulin Ab
    19. TPO Ab
    20. TSH

    D. Tumor Markers And Special Chemistry Tests
    1. AFP
    2. CA 15-3
    3. CA 19-9
    4. CA 27-29
    5. Carcinoembrionic Antigen (CEA)
    6. Folate/Folic Acid
    7. HCG
    8. 25-Hydroxy Vitamin D2 and D3
    9. Occult Blood
    10. Prostate-Specific Antigen (PSA)
    11. Thyroglobulin
    12. Vitamin B-12
    E. Immunoprotein Tests
    1. Complement
    a. C3
    b. C4
    2. Free Light Chains
    3. Immunofixation
    4. Immunoglobulins (IgA, IgE, IgG, IgM)
    5. Haptoglobin
    6. Prealbumin
    7. Protein Electrophoresis
    F. Drugs of Abuse
    1. Overview
    2. Test Methodologies
    3. Amphetamines
    4. Barbiturates
    5. Benzodiazepines
    6. Cannabinoids/Marijuana
    7. Cocaine
    8. Lysergic Acid Diethylamide (LSD)
    9. Methadone
    10. Methaqualone
    11. Opiates
    12. Phencyclidine
    13. Tricyclic Antidepressants

    G. Instrumentation Review: Operating Characteristics
    and Features of High-, Medium-, and Low- Volume/POC
    Analyzers Manufactured By:
    Abaxis
    Abbott
    Alere/Inverness
    Alfa Wassermann
    AMS
    Awareness Technologies
    Beckman Coulter/Olympus
    Binding Site
    bioMerieux
    Carolina Chemistries
    DiaSorin
    Grifols
    Horiba
    Medica
    Nova Biomedical
    Ortho-Clinical Diagnostics
    Polymedco
    Randox
    Roche
    Siemens
    Tosoh
    Vital Diagnostics
    H. Major In Vitro Diagnostic Technologies
    And Their Potential Applications
    1. Monoclonal and Polyclonal Antibodies
    2. Immunoassays
    a. Technological Principle
    d. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
    Overview
    ELISA
    EMIT
    Electrochemical


    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography

    3. Tandem Mass Spec
    4. IT and Automation
    5. Dry Chemistry
    6. Biosensors
    U.S.A.
    A. Executive Summary
    B. Business Environment
    1. Health Care Expenditures
    2. Cost Consciousness
    3. Industry Consolidation
    4. Managed Care
    5. Hospitals
    6. Admissions
    7. Length of Stay
    8. Industry Diversification
    9. Physician Demographics
    10. Population Aging
    a. Chronic Illness
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
    11. Laboratory Regulations
    C. Market Structure
    1. Centralized Testing
    a. Hospitals
    b. Commercial/Private Laboratories
    2. Decentralized Testing
    a. Physician Offices/Group Practices
    b. Point-of-Care Testing
    c. Home/Self Testing
    d. Other Decentralized Testing Locations
    D. Market Size, Growth and Major Suppliers
    Instrument and Reagent Sales and Market Shares

    Major Product Development Opportunities
    Design Criteria for Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
    1. Marketing Approaches
    2. Product Complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types of Distributors
    7. Market Segmentation
    Potential Market Entry Barriers and Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge and Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Competitive Assessments
    - Abbott Laboratories
    - AdnaGen/Alere
    - Agilent Technologies
    - Bayer Healthcare
    - Beckman Coulter/Danaher
    - Biomedical Diagnostics
    - BioMerieux
    - Bio-Rad

    - DiaSorin
    - Eiken
    - Fujirebio
    - Grifols
    - Instrumentation Laboratory
    - Kyowa Medex
    - Matritech/Alere
    - Ortho-Clinical Diagnostics
    - Quest Diagnostics
    - Roche
    - Siemens
    - Sysmex
    - Thermo Fisher
    - Tosoh
    - Wako
    - Wallac/PE

    List Of Tables


    Major Companies Developing or Marketing
    Albumin Tests
    Major Companies Developing or Marketing
    Alkaline Phosphatase Tests
    Major Companies Developing or Marketing
    ALT/SGPT Tests
    Major Companies Developing or Marketing
    Amylase Tests
    Major Companies Developing or Marketing
    AST/SGOT Tests
    Major Companies Developing or Marketing
    Bilirubin Tests
    Major Companies Developing or Marketing
    Blood Gas Analyzers
    Major Companies Developing or Marketing
    BUN Tests
    Major Companies Developing or Marketing
    Calcium Tests
    Major Companies Developing or Marketing
    Cholesterol Tests
    Major Companies Developing or Marketing
    Creatinine Tests
    Major Companies Developing or Marketing
    Electrolyte Tests


    Major Companies Developing or Marketing
    GGT Tests
    Major Companies Developing or Marketing
    Glucose Tests
    Major Companies Developing or Marketing
    HDL Tests
    Major Companies Developing or Marketing
    Iron Tests
    Major Companies Developing or Marketing
    LDH Tests
    Major Companies Developing or Marketing
    Magnesium Tests
    Major Companies Developing or Marketing
    Phosphorus Tests
    Major Companies Developing or Marketing
    Protein Tests
    Major Companies Developing or Marketing
    Triglycerides Tests
    Major Companies Developing or Marketing
    Uric Acid Tests
    Major Companies Developing or Marketing
    TDM Tests
    Major Companies Developing or Marketing
    Digoxin Tests
    Major Companies Developing or Marketing
    Lithium Tests
    Major Companies Developing or Marketing
    Phenytoin/Dilantin Tests

    Major Companies Developing or Marketing
    Theophylline Tests
    Major Companies Developing or Marketing
    Valproic Acid Tests
    Major Companies Developing or Marketing
    FSH Tests
    Major Companies Developing or Marketing
    HCG Tests
    Major Companies Developing or Marketing
    LH Tests
    Major Companies Developing or Marketing
    Prolactin Tests
    Major Companies Developing or Marketing
    T3 Tests
    Major Companies Developing or Marketing
    T4 Tests
    Major Companies Developing or Marketing
    TSH Tests
    Major Companies Developing or Marketing
    AFP Tests
    Major Companies Developing or Marketing
    CEA Tests
    Major Companies Developing or Marketing
    Ferritin Tests
    Major Companies Developing or Marketing
    Occult Blood Tests
    Major Companies Developing or Marketing
    Prostatic Acid Phosphatase Tests

    Major Companies Developing or Marketing
    PSA Tests
    Major Companies Developing or Marketing
    Vitamin B-12/Folate Tests
    Major Companies Developing or Marketing
    CRP Tests
    Major Companies Developing or Marketing
    Drugs of Abuse Tests
    Major Companies Developing or Marketing
    Biosensors for Immunological Testing
    Executive Summary Table: U.S.A., Clinical
    Chemistry and Immunoassay Test Volume
    and Diagnostics Sales Forecast By Test Category
    U.S.A., Hospital Laboratories Performing
    Chemistry and Immunoassay Tests By Bed Size
    U.S.A., Hospital Laboratories, Profiles,
    Panels and Individual Tests Forecast
    U.S.A., Hospital Laboratories, Routine
    Chemistry Test Volume Forecast
    by Assay
    U.S.A., Hospital Laboratories, TDM
    Test Volume Forecast by Assay
    U.S.A., Hospital Laboratories, Endocrine
    Function Test Volume Forecast by Assay
    U.S.A., Hospital Laboratories, Drugs
    of Abuse Test Volume Forecast by Assay


    U.S.A., Hospital Laboratories, Tumor Markers
    and Special Chemistry Test Volume Forecast
    by Assay
    U.S.A., Hospital Laboratories,
    Immunoprotein Test Volume Forecast
    by Assay
    U.S.A., Hospital Laboratories, Routine
    Chemistry Reagent Market Forecast
    by Assay
    U.S.A., Hospital Laboratories, Endocrine
    Function Reagent Market Forecast by Assay
    U.S.A., Hospital Laboratories, Tumor Markers
    and Special Chemistry Reagent Market Forecast
    by Assay
    U.S.A., Hospital Laboratories, Immunoprotein
    Reagent Market Forecast by Assay
    U.S.A., Hospital Laboratories, TDM
    Reagent Market Forecast by Assay
    U.S.A., Hospital Laboratories, Drugs of
    Abuse Reagent Market Forecast by Assay
    U.S.A., Clinical Chemistry and Immunoassay
    Instrument Market Forecast by Analyzer Type
    U.S.A., Major Suppliers of Clinical Chemistry
    Diagnostics Products, Estimated Sales
    and Market Shares

    U.S.A., Major Suppliers of Immunoassay
    Diagnostics Products, Estimated Sales
    And Market Shares


    Cyprus Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

    This comprehensive report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.

    USD 2750 View Report

    Austria Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

    This comprehensive report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.

    USD 2750 View Report

    UK Hospital Clinical Chemistry and Immunodiagnostics Market for 100 Tests: Supplier Shares and Sales Forecasts, 2019-2023

    This new report contains 523 pages, 64 tables, and presents a comprehensive analysis of the UK hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the UK clinical chemistry

    USD 2450 View Report

    Spain Hospital Clinical Chemistry and Immunodiagnostics Market for 100 Tests: Supplier Shares and Sales Forecasts, 2019-2023

    This new report contains 514 pages, 63 tables, and presents a comprehensive analysis of the Spanish hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the Spanish clinical chemistry

    USD 2450 View Report

    Fill The Form For Sample Request

    Note : * Kindly provide us with your company id and get the sample reports at the earliest.

    There is no Reviews available